Blaine McKee
Director/Board Member at VBI VACCINES INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Athena Kartsaklis | F | 59 | 7 years | |
| Nell Beattie | F | 36 | 9 years | |
| Steven Gillis | M | 71 |
Walden Biosciences, Inc.
 Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | 19 years |
| Jeff Baxter | M | 62 | 8 years | |
| Vaughn Himes | M | 63 | 1 years | |
| James Shmerling | M | 69 | 6 years | |
| Mathias Schmidt | M | 56 |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | 8 years |
| Nicole Anderson | F | - | 7 years | |
| Jason Jing Chen | M | 62 | 6 years | |
| Misha Nossov | M | - | 14 years | |
| Joanne Cordeiro | F | 66 | 5 years | |
| Ari Nowacek | M | - |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | - |
| Michel de Wilde | M | 74 | 8 years | |
| Anat Naschitz | F | 56 |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | 14 years |
| Eric S. Lander | M | 67 |
Massachusetts Institute of Technology
| 34 years |
| Damian Braga | M | 68 | 4 years | |
| Mark Goldberg | M | 69 |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA.
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 years |
| Francisco Diaz-Mitoma | M | 69 | 8 years | |
| Peter G. Linde | M | 57 |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | 2 years |
| John B. Vander Sande | M | 79 |
Massachusetts Institute of Technology
| 32 years |
| Hong Yu | M | 52 | 6 years | |
| Nissim Darvish | M | 59 |
OrbiMed Israel Partners LP
OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | 14 years |
| Erez Chimovits | M | 60 |
OrbiMed Israel Partners LP
OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | - |
| John Dillman | M | 56 | 2 years | |
| William Fodor | M | 65 | 7 years | |
| David Anderson | M | 54 | 8 years | |
| Klavis Jensen | M | 71 |
Massachusetts Institute of Technology
| 35 years |
| Emmanuel Lacroix | M | - |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | - |
| Kathleen Fanning | F | - |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | - |
| John Deutch | M | 85 |
Massachusetts Institute of Technology
| 34 years |
| Curt Dewan | M | - |
Walden Biosciences, Inc.
Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Junius | M | 71 | 13 years | |
| Linda Bain | F | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
| David B. Johnston | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| David Green | M | 60 | 4 years | |
| James Bowling | M | 56 | 10 years | |
| Christopher McNulty | M | 47 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 7 years |
| John F. Kennedy | M | 75 | 6 years | |
| Scott Applebaum | M | 57 | 2 years | |
| Jeffrey Poulton | M | 56 | 14 years | |
| Earl Collier | M | 76 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 17 years |
| Michael A. Klug | M | - |
Massachusetts Institute of Technology
| 12 years |
| Eric Oliver | M | - |
Massachusetts Institute of Technology
| 7 years |
| Reza Abhari | M | 62 |
Massachusetts Institute of Technology
| 3 years |
| Walid Fakhry | M | - |
Massachusetts Institute of Technology
| 6 years |
| Scott A. Miller | M | - |
Massachusetts Institute of Technology
| 5 years |
| Warren Chen | M | - |
Massachusetts Institute of Technology
| 4 years |
| Roger W. Louis | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Yong Gang Ren | M | 59 |
Massachusetts Institute of Technology
| 5 years |
| Steven Burke | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Chan Yoo | M | 59 |
Massachusetts Institute of Technology
| 8 years |
| Ralph Victor Whitworth | M | 68 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Wei Zhang | M | 52 | 3 years | |
| David Altarac | M | 63 | - | |
| Bryan R. Smith | M | - |
Massachusetts Institute of Technology
| - |
| Saverio la Francesca | M | 62 | 3 years | |
| Richard Gregory | M | 66 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 years |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 years |
| Michael Halpin | M | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Julie Feder | F | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| James Eric Callaway | M | 68 |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | 4 years |
| Ludovic Robin | M | - | 8 years | |
| Errol Arkilic | M | - |
Massachusetts Institute of Technology
| 6 years |
| Christoph Brackmann | M | - | - | |
| Brian Schiller | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 years |
| Sun Kim | M | 52 | 2 years | |
| Neil Renninger | M | 49 |
Massachusetts Institute of Technology
| 5 years |
| Mohsin Ansari | M | - |
Massachusetts Institute of Technology
| 5 years |
| Mark Enyedy | M | 60 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 3 years |
| Mike McElroy | M | - |
Massachusetts Institute of Technology
| 9 years |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 years |
| Ian Clark | M | 62 | 2 years | |
| Thomas H. Robinson | M | 65 | 6 years | |
| Christopher J. Neil | M | 58 |
Massachusetts Institute of Technology
| 6 years |
| Richard F. Syron | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Alan Smith | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 22 years |
| Peter Wirth | M | 73 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 years |
| Henry E. Blair | M | 80 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 26 years |
| David Stout | M | 69 | 6 years | |
| Philippe Laffont | M | - |
Massachusetts Institute of Technology
| 6 years |
| Cornelius McGillicuddy | M | 83 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| David John Kappler | M | 76 | 12 years | |
| Joe Schirripa | M | - |
Massachusetts Institute of Technology
| 6 years |
| Ben Shih | M | - |
Massachusetts Institute of Technology
| 4 years |
| Anastasios Aslidis | M | 64 |
Massachusetts Institute of Technology
| 3 years |
| Gregory Lambrecht | M | - |
Massachusetts Institute of Technology
| 6 years |
| Louis J. Arcudi | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
| Mihnea Moldoveanu | M | - |
Massachusetts Institute of Technology
| 5 years |
| John J. Canepa | M | 68 | 5 years | |
| Evren Ünver | M | - |
Massachusetts Institute of Technology
| 5 years |
| Scott Requadt | M | 56 | 3 years | |
| Adrianna Ma | F | 50 |
Massachusetts Institute of Technology
| 5 years |
| Peter T. Traynor | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Andrew C. Singer | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jonathan Sheena | M | 51 |
Massachusetts Institute of Technology
| 6 years |
| Albert Wong | M | 61 |
Massachusetts Institute of Technology
| 3 years |
| Suresh Thirugnanam | M | 60 |
Massachusetts Institute of Technology
| 4 years |
| Subodh Kulkarni | M | 60 |
Massachusetts Institute of Technology
| 4 years |
| Ron Gimbel | M | - |
Colorado State University
| 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 89 | 89.90% |
| Ireland | 11 | 11.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Blaine McKee
- Personal Network